Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2010
11/09/2010US7829667 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
11/09/2010US7829666 toxins belonging to the same structural class of K+ channel-acting short-chain scorpion toxins (less than 40 amino acid residues) that are cross-linked by four disulfide bridges; modulating a K+ channel in a cell; nerve disorder therapy
11/09/2010US7829663 F11 receptor (F11R) antagonists as therapeutic agents
11/09/2010US7829662 BH3 interacting domain death agonist for use in prevention ans treatment of apoptosis associated disorders
11/09/2010US7829659 Methods of modifying polypeptides comprising non-natural amino acids
11/09/2010US7829545 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
11/09/2010US7829537 drug biological conjugates used in the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers
11/09/2010US7829536 administering to a patient with lymphedema a therapeutically effective amount of a vascular endothelial growth factor D (VEGF-D) protein at the site of edema, that binds and stimulates wild-type VEGFR-3; genetic disorders; screening
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7829529 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
11/09/2010US7829528 Compositions and methods for treating STAT-6 associated diseases or conditions
11/09/2010US7829526 DNA encoding peptide, an antibody against the peptide; cardioinhibitory, hypotensive agent; peptide as an active ingredient; marker protein, peptide tag
11/09/2010US7829525 a surface active substance, in particular a non-ionic detergent (tenside), and a mixture of at least two amino acids, are either Glu and Gln or Asp and Asn for stabilization of protein agents in pharmaceuticals
11/09/2010US7829524 nucleic acid constructs, vectors, and host cells; detergents; transgenic plants; animal feeds
11/09/2010US7829523 Method for stabilizing polypeptides lacking methionine
11/09/2010US7829338 Dominant negative alleles of human mismatch repair genes introduced into cells and transgenic animals; prepared more efficiently than by relying on the natural rate of mutation
11/09/2010US7829336 Method for isolating a self-renewing, multipotent, slow-cycling cell
11/09/2010US7829333 Modulation of hedgehog-mediated signaling pathway
11/09/2010US7829330 Stresscopins and their uses
11/09/2010US7829321 Method for the production of bacterial toxins
11/09/2010US7829311 Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
11/09/2010US7829310 Compositions of aminoacyl-tRNA synthetase and uses thereof
11/09/2010US7829308 Neurogenin
11/09/2010US7829307 Multimeric protein with linker having sequence ProValSerGlyProArg; [Gly2]hGLP-2 is produced from a multimeric precursor; genetic engineering and expression; biodrugs
11/09/2010US7829300 Method of measuring the activity of G(alpha)i- or G(alpha)o-coupled receptors using Ca2+ influx in cells
11/09/2010US7829299 Using G-protein coupled receptors to identify modulators of flavors; enhancing drug and food palatability
11/09/2010US7829297 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor
11/09/2010US7829293 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders
11/09/2010US7829276 Using conditionally replication-competent adenoviruses transcription as diagnostic indicator of cell proliferative disorders of alimentary canal; tissue targeted therapy; drug delivery
11/09/2010US7829103 immunogenic composition consisting of, as an active principle, a pure methylated heparin-binding hemagglutinin (HBHA) protein in a pharmaceutically acceptable formulation, and one or more adjuvants
11/09/2010US7829102 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s)
11/09/2010US7829092 Recombinant anti-VLA4 antibody molecules
11/09/2010US7829091 Therapy targeting FLT4 (VEGER-3) expressed in blood vessels
11/09/2010US7829089 Antibody to mammalian cytokine-like polypeptide-10
11/09/2010US7829083 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2
11/09/2010US7829078 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery; increasing the hematocrit and/or the reticulocyte count in a mammalian subject
11/09/2010US7829077 kit comprising an IFN- alpha selected from IFN- alpha -2a, IFN- alpha -2b, IFN- alpha -5, consensus interferon, purified IFN- alpha , pegylated IFN- alpha and a pharmaceutically acceptable quantity of oncostatin M
11/09/2010US7829076 increase the production of monocytic cells or moncyte cell progenitors by culturing bone marrow or blood cells with a polypeptide for use in treatment and prevention of viral hepatitis diseases; N-terminal methionine; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, systemic lupus, leukemia
11/09/2010US7829075 Method for expanding hematopoietic cells using cytokine zalpha11 ligand
11/09/2010US7829072 Hypoallergens
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/09/2010CA2362794C Inhibitors of separase, method for identifying them and uses
11/09/2010CA2342305C Pestivirus mutants and vaccines containing the same
11/09/2010CA2328462C Efficient purification of adenovirus
11/09/2010CA2223532C Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
11/09/2010CA2208420C Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/04/2010WO2010127258A1 A novel subtype of clostridium botulinum neurotoxin type a and uses thereof
11/04/2010WO2010127119A2 Multiphasic microfibers for spatially guided cell growth
11/04/2010WO2010126993A1 Immunoreactive ehrlichia p120/p140 epitopes and uses thereof
11/04/2010WO2010126766A1 Inducible interleukin-12
11/04/2010WO2010126732A1 Hybrid prokaryotic-eukaryotic tubulins and use thereof
11/04/2010WO2010126211A1 Composition for preventing and curing lung cancer containing mutant osteopontin or expression inhibitor
11/04/2010WO2010126151A1 Novel malaria vaccine
11/04/2010WO2010126139A1 Protein-type electron mediator
11/04/2010WO2010126043A1 Kidney disease detection method that includes measurement of human megalin in urine
11/04/2010WO2010125910A1 Collagen peptide composition having good blood transfer properties, and food and drink containing same
11/04/2010WO2010125588A1 Novel fusion tag offering solubility to insoluble recombinant protein
11/04/2010WO2010125296A1 Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof
11/04/2010WO2010125293A1 Targeting nucleic acids in the mitochondria
11/04/2010WO2010125192A1 Use of a casein-derived peptide and compositions thereof as antihypertensive
11/04/2010WO2010125175A1 A fungal serine protease and use thereof
11/04/2010WO2010125174A1 A novel fungal protease and use thereof
11/04/2010WO2010125163A1 Composite material comprising crosslinkable resin of proteinous material
11/04/2010WO2010125091A1 New competence stimulating peptide
11/04/2010WO2010125079A2 Insulinotropic peptide synthesis using solid and solution phase combination techniques
11/04/2010WO2010124953A1 Plants having enhanced yield-related traits and a method for making the same
11/04/2010WO2010124843A2 Use of silintaphin for the structure-directed fabrication of (nano) composite materials in medicine and (nano) technology
11/04/2010WO2010124373A1 Influenza vaccine
11/04/2010WO2010124365A1 Compositions and methods for modulating stem cells and uses thereof
11/04/2010WO2010124361A1 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
11/04/2010WO2010105128A3 A pkn3/rhoc macromolecular complex and methods of use therefor
11/04/2010WO2010105097A3 Sparc angiogenic domain and methods of use
11/04/2010WO2010089402A9 Splitting gp41
11/04/2010WO2010085373A3 Novel bacillus thuringiensis gene with lepidopteran activity
11/04/2010WO2010056966A3 Novel hiv-2 isolate
11/04/2010WO2010056108A3 Extract having protease activity
11/04/2010WO2010029363A3 Cathepsin s propeptide fragments
11/04/2010US20100281583 Boron transporter
11/04/2010US20100281578 Yield Enhancement in Plants by Modulation of AP2 Transcription Factor
11/04/2010US20100281577 Plant haemoglobin
11/04/2010US20100281576 Cytochrome p450 gene for increasing seed size or water stress resistance of plant
11/04/2010US20100281572 Nematode resistant transgenic plants
11/04/2010US20100281571 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield
11/04/2010US20100281566 Transcriptional control element, chimeric consructs and uses therefor
11/04/2010US20100281550 Factor involved in latent infection with herpesvirus, and use thereof
11/04/2010US20100281549 Transgenic Production In Saliva
11/04/2010US20100280229 Polypeptide
11/04/2010US20100280226 Method for using nano carbon to refine collagen into nanoparticulate collagen
11/04/2010US20100280225 Fungus-induced inflammation and eosinophil degranulation
11/04/2010US20100280224 Marker sequences for multiple sclerosis and use thereof
11/04/2010US20100280223 method for determining and predicting protein autonomous folding
11/04/2010US20100280222 Clostridial neurotoxin compositions and modified clostridial neurotoxins
11/04/2010US20100279980 Moenomycin biosynthesis-related compositions and methods of use thereof
11/04/2010US20100279952 Cross-linked hydrogel containing an active substance
11/04/2010US20100279950 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
11/04/2010US20100279949 Process for preparing recombinant heterocarpine
11/04/2010US20100279947 Modifications of apoptin
11/04/2010US20100279942 Methods for treating motor neuron disease
11/04/2010US20100279940 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 2916